On the one hand, Ngb can support hypoxia-mediated defences to allow cancer cells to adapt to the tumour microenvironment, and on the other, it may enable tumour suppressor capacities in other malignant cells [33, 110, 112, 129, 130]. This evidence concerns the gene NGB and neoplasm.